Oncology Institute (TOI) Revenue (2021 - 2026)

Oncology Institute (TOI) has 6 years of Revenue data on file, last reported at $147.4 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 41.22% year-over-year to $147.4 million; the trailing twelve-month figure through Mar 2026 stood at $545.8 million (up 35.37% YoY), and the FY2025 full-year result was $502.7 million, up 27.79% from the prior year.
• Revenue for Q1 2026 stood at $147.4 million, up from $142.0 million in the prior quarter.
• Across five years, Revenue topped out at $147.4 million in Q1 2026 and bottomed at $55.2 million in Q1 2022.
• The 5-year median for Revenue is $94.7 million (2024), against an average of $95.3 million.
• Peak annual rise in Revenue reached 41.58% in 2025, while the deepest fall reached 10.29% in 2025.
• A 5-year view of Revenue shows it stood at $71.4 million in 2022, then climbed by 20.11% to $85.8 million in 2023, then climbed by 16.88% to $100.3 million in 2024, then soared by 41.58% to $142.0 million in 2025, then increased by 3.86% to $147.4 million in 2026.
• The last three Revenue figures came in at $147.4 million (Q1 2026), $142.0 million (Q4 2025), and $136.6 million (Q3 2025), per Business Quant data.

Peer Comparison